アレルギー免疫療法の世界市場2020-2027:治療タイプ別(SCIT、SLIT)、アレルギータイプ別、販売チャネル別、地域別

◆英語タイトル:Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (SCIT, SLIT), By Allergy Type (Allergic Rhinitis, Asthma), By Distribution Channel, By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20JN030
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年5月
◆ページ数:102
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2週間)
◆調査対象地域:クローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥722,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥930,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、アレルギー免疫療法の世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、治療タイプ別(SCIT、SLIT)分析、アレルギータイプ別分析、販売チャネル別分析、地域別分析、競争状況など、今後の市場展望をまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場の要因・動向・範囲
・アレルギー免疫療法の世界市場規模:治療タイプ別(SCIT、SLIT)
・アレルギー免疫療法の世界市場規模:アレルギータイプ別
・アレルギー免疫療法の世界市場規模:販売チャネル別
・アレルギー免疫療法の世界市場規模:地域別
・競争状況
【レポートの概要】

Allergy Immunotherapy Market Trends & Growth

The global allergy immunotherapy market size is expected to reach USD 3.1 billion by 2027 registering a CAGR of 9.0%, according to a new report by Grand View Research, Inc. Rising prevalence of allergic conditions is expected to boost the market growth. According to the statistics published by the American Academy of Allergy, Asthma & Immunology (AAAAI), global prevalence of allergic rhinitis ranges from 10% to 30%. The disease affects 7.8% of the adult population in U.S. alone.

Technological advancements in the field of bioengineering and immunology have improved the composition of allergy shots given to patients for boosting the immune system. In addition, efforts to overcome the problems associated with safety, efficacy, standardization, costs, and long duration of immunotherapy is also expected to propel the market growth in the coming years. Europe occupied the largest market share in 2019 and will retain its leading position during the forecast period. However, Asia Pacific is estimated to be the fastest-growing regional market from 2020 to 2027.

Allergy Immunotherapy Market Report Highlights

• Subcutaneous Immunotherapy (SCIT) segment generated the maximum revenue in 2019 as SCIT is the most effective and highly adopted form of allergy immunotherapy

• SCIT can be used for the treatment of a wide range of disorders including allergic rhinitis, asthma, and stinging insect hypersensitivity

• However, Sublingual Immunotherapy (SLIT) has emerged as a safe & effective alternative for SCIT

• During SLIT, the allergen is administered under the tongue in the form of tablets or drops

• Allergic rhinitis was the largest revenue-generating segment in 2019 and is estimated to maintain its dominance throughout the forecast period owing to the high disease burden across the globe

• Hospital pharmacy segment held the largest share in 2019 owing to a rise in the patient pool for treatment of allergic disorders in hospitals

• ASIT Biotech; Circassia; Mylan N.V.; Adamis Pharmaceuticals Corp.; Merck KGaA; Stallergenes Greer plc.; Allergy Therapeutics; ALK-Abelló A/S; DESENTUM OY; HAL Allergy B.V.; HollisterStier Allergy; LETIPharma; and DBV Technologies SA are the prominent participants operating in this market

【レポートの目次】

Table of Contents

Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased database:
2.1.2 GVR’s Internal Database
2.1.3 Secondary sources:
2.1.4 Primary Research:
2.1.5 Details of Primary Research
2.1.5.1 Data for primary interviews in North America
2.1.5.2 Data for primary interviews in Europe
2.1.5.3 Data for primary interviews in Asia-Pacific
2.1.5.4 Data for primary interviews in Latin America
2.1.5.5 Data for primary interviews in MEA
2.2 Information or Data Analysis
2.2.1 Data Analysis Models
2.3 Market Formulation & Validation
2.4 Model Details
2.4.1 Commodity flow analysis (Model 1)
2.4.1.1 Approach 1: Commodity flow approach
2.5 List of Secondary Sources
2.6 List of Primary Sources
2.7 Objectives
2.7.1 Objective 1
2.7.2 Objective 2
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Rise in the prevalence of allergic disorders
3.1.1.2 Technological advancements in sublingual dosage formulations
3.1.1.3 Presence fo strong product pipeline
3.1.2 Market restraint analysis
3.1.2.1 Drawbacks associated with the use of allergy immunotherapy
3.2 Penetration & Growth Prospect Mapping for Allergy Type, 2019
3.3 Allergy Immunotherapy -SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
3.5 Pipeline Analysis
Chapter 4 Allergy Immunotherapy Market Categorization: Treatment Type Estimates & Trend Analysis
4.1 Allergy Immunotherapy Market: Treatment Type Movement Analysis, 2019 & 2027
4.2 Subcutaneous Immunotherapy (SCIT)
4.2.1 Allergy immunotherapy market for SCIT, 2016 – 2027 (USD Million)
4.3 Sublingual Immunotherapy (SLIT)
4.3.1 Allergy immunotherapy market for SLIT, 2016 – 2027 (USD Million)
4.3.2 Tablets
4.3.2.1 SLIT tablets market, 2016 – 2027 (USD Million)
4.3.3 Drops
4.3.3.1 SLIT drops market, 2016 – 2027 (USD Million)
Chapter 5 Allergy Immunotherapy Market Categorization: Allergy Type Estimates & Trend Analysis
5.1 Allergy Immunotherapy Market: Allergy Type Movement Analysis, 2019 & 2027
5.2 Allergic Rhinitis
5.2.1 Allergy immunotherapy market for allergic rhinitis, 2016 – 2027 (USD Million)
5.3 Allergic Asthma
5.3.1 Allergy immunotherapy market for allergic asthma, 2016 – 2027 (USD Million)
5.4 Other Allergies
5.4.1 Allergy immunotherapy market for other allergies, 2016 – 2027 (USD Million)
Chapter 6 Allergy Immunotherapy Market Categorization: Distribution Channel Estimates & Trend Analysis
6.1 Allergy Immunotherapy Market: Distribution Channel Movement Analysis, 2019 & 2027
6.2 Hospital Pharmacy
6.2.1 Allergy immunotherapy market for hospital pharmacy, 2016 – 2027 (USD Million)
6.3 Retail Pharmacy
6.3.1 Allergy immunotherapy market for retail pharmacy, 2016 – 2027 (USD Million)
6.4 Online Pharmacy
6.4.1 Allergy immunotherapy market for online pharmacy, 2016 – 2027 (USD Million)
Chapter 7 Market Categorization: Regional Estimates & Trend Analysis, by Treatment Type, Allergy Type, and Distribution Channel
7.1 Allergy Immunotherapy Market Share By Region, 2019 & 2027
7.2 North America
7.2.1 North America allergy immunotherapy market, 2016 – 2027 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. allergy immunotherapy market, by treatment type, 2016 – 2027 (USD Million)
7.2.2.2 U.S. allergy immunotherapy market, by allergy type, 2016 – 2027 (USD Million)
7.2.2.3 U.S. allergy immunotherapy market, by distribution channel, 2016 – 2027 (USD Million)
7.2.3 Canada
7.2.3.1 Canada allergy immunotherapy market, by treatment type, 2016 – 2027 (USD Million)
7.2.3.2 Canada allergy immunotherapy market, by allergy type, 2016 – 2027 (USD Million)
7.2.3.3 Canada allergy immunotherapy market, by distribution channel, 2016 – 2027 (USD Million)
7.3 Europe
7.3.1 Europe allergy immunotherapy market, 2016 – 2027 (USD Million)
7.3.2 Germany
7.3.2.1 Germany allergy immunotherapy market, by treatment type, 2016 – 2027 (USD Million)
7.3.2.2 Germany allergy immunotherapy market, by allergy type, 2016 – 2027 (USD Million)
7.3.2.3 Germany allergy immunotherapy market, by distribution channel, 2016 – 2027 (USD Million)
7.3.3 France
7.3.3.1 France allergy immunotherapy market, by treatment type, 2016 – 2027 (USD Million)
7.3.3.2 France allergy immunotherapy market, by allergy type, 2016 – 2027 (USD Million)
7.3.3.3 France allergy immunotherapy market, by distribution channel, 2016 – 2027 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific allergy immunotherapy market, 2016 – 2027 (USD Million)
7.4.2 Japan
7.4.2.1 Japan allergy immunotherapy market, by treatment type, 2016 – 2027 (USD Million)
7.4.2.2 Japan allergy immunotherapy market, by allergy type, 2016 – 2027 (USD Million)
7.4.2.3 Japan allergy immunotherapy market, by distribution channel, 2016 – 2027 (USD Million)
7.4.3 China
7.4.3.1 China allergy immunotherapy market, by treatment type, 2016 – 2027 (USD Million)
7.4.3.2 China allergy immunotherapy market, by allergy type, 2016 – 2027 (USD Million)
7.4.3.3 China allergy immunotherapy market, by distribution channel, 2016 – 2027 (USD Million)
7.5 Latin America
7.5.1 Latin America allergy immunotherapy market, 2016 – 2027 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil allergy immunotherapy market, by treatment type, 2016 – 2027 (USD Million)
7.5.2.2 Brazil allergy immunotherapy market, by allergy type, 2016 – 2027 (USD Million)
7.5.2.3 Brazil allergy immunotherapy market, by distribution channel, 2016 – 2027 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico allergy immunotherapy market, by treatment type, 2016 – 2027 (USD Million)
7.5.3.2 Mexico allergy immunotherapy market, by allergy type, 2016 – 2027 (USD Million)
7.5.3.3 Mexico allergy immunotherapy market, by distribution channel, 2016 – 2027 (USD Million)
7.6 Middle East & Africa
7.6.1 Middle East & Africa allergy immunotherapy market, 2016 – 2027 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa allergy immunotherapy market, by treatment type, 2016 – 2027 (USD Million)
7.6.2.2 South Africa allergy immunotherapy market, by allergy type, 2016 – 2027 (USD Million)
7.6.2.3 South Africa allergy immunotherapy market, by distribution channel, 2016 – 2027 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia allergy immunotherapy market, by treatment type, 2016 – 2027 (USD Million)
7.6.3.2 Saudi Arabia allergy immunotherapy market, by allergy type, 2016 – 2027 (USD Million)
7.6.3.3 Saudi Arabia allergy immunotherapy market, by distribution channel, 2016 – 2027 (USD Million)
Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 Adamis Pharmaceuticals Corporation
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 ALK-Abelló A/S
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 Allergy Therapeutics
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 ASIT Biotech
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 Circassia
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 DBV Technologies SA
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 DESENTUM OY
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 HAL Allergy B.V.
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 HollisterStier Allergy
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 LETIPharma
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 Merck KGaA
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.11.4 Strategic initiatives
8.3.12 Mylan N.V.
8.3.12.1 Company overview
8.3.12.2 Financial performance
8.3.12.3 Product benchmarking
8.3.12.4 Strategic initiatives
8.3.13 Stallergenes Greer plc
8.3.13.1 Company overview
8.3.13.2 Financial performance
8.3.13.3 Product benchmarking
8.3.13.4 Strategic initiatives

List of Tables

TABLE 1 Primary interview details: North America
TABLE 2 Primary interview details: Europe
TABLE 3 Primary interview details: Asia-Pacific
TABLE 4 Primary interview details: Latin America
TABLE 5 Primary interview details: MEA
TABLE 6 List of secondary sources
TABLE 7 Sublingual immunotherapy allergy tablets: Key products
TABLE 8 North America allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 9 North America sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 10 North America allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 11 North America allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)
TABLE 12 U.S. allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 13 U.S. sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 14 U.S. allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 15 U.S. allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)
TABLE 16 Canada allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 17 Canada sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 18 Canada allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 19 Canada allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)
TABLE 20 Europe allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 21 Europe sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 22 Europe allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 23 Europe allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)
TABLE 24 Germany allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 25 Germany sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 26 Germany allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 27 Germany allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)
TABLE 28 France allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 29 France sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 30 France allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 31 France allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)
TABLE 32 Asia Pacific allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 33 Asia Pacific sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 34 Asia Pacific allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 35 Asia Pacific allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)
TABLE 36 Japan allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 37 Japan sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 38 Japan allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 39 Japan allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)
TABLE 40 China allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 41 China sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 42 China allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 43 China allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)
TABLE 44 Latin America allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 45 Latin America sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 46 Latin America allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 47 Latin America allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)
TABLE 48 Brazil allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 49 Brazil sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 50 Brazil allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 51 Brazil allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)
TABLE 52 Mexico allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 53 Mexico sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 54 Mexico allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 55 Mexico allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)
TABLE 56 Middle East & Africa allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 57 Middle East & Africa sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 58 Middle East & Africa allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 59 Middle East & Africa allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)
TABLE 60 South Africa allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 61 South Africa sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 62 South Africa allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 63 South Africa allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)
TABLE 64 Saudi Arabia allergy immunotherapy market estimates & forecasts, by therapy type, 2016 - 2027 (USD Million)
TABLE 65 Saudi Arabia sublingual immunotherapy market estimates & forecasts, by type, 2016 - 2027 (USD Million)
TABLE 66 Saudi Arabia allergy immunotherapy market estimates & forecasts, by allergy type, 2016 - 2027 (USD Million)
TABLE 67 Saudi Arabia allergy immunotherapy market estimates & forecasts, by distribution channel, 2016 - 2027 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[アレルギー免疫療法の世界市場2020-2027:治療タイプ別(SCIT、SLIT)、アレルギータイプ別、販売チャネル別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆